Preferred Label : Receptor for Advanced Glycation End Products;

MeSH definition : A single-pass transmembrane CELL SURFACE RECEPTOR that binds ADVANCED GLYCOSYLATION END PRODUCTS to mediate cellular responses to both acute and chronic vascular inflammation in conditions such as ATHEROSCLEROSIS and DIABETES MELLITUS, TYPE 2 . It also binds AMYLOID BETA PEPTIDES and the alarmins S100A12 and S100 CALCIUM BINDING PROTEIN BETA SUBUNIT.; A single-pass transmembrane CELL SURFACE RECEPTOR that binds ADVANCED GLYCATION END PRODUCTS to mediate cellular responses to both acute and chronic vascular inflammation in conditions such as ATHEROSCLEROSIS and DIABETES MELLITUS, TYPE 2. It also binds AMYLOID BETA PEPTIDES and the ALARMINS - S100A12 and S100 CALCIUM BINDING PROTEIN BETA SUBUNIT.; A single-pass transmembrane CELL SURFACE RECEPTOR that binds ADVANCED GLYCATION END PRODUCTS to mediate cellular responses to both acute and chronic vascular inflammation in conditions such as ATHEROSCLEROSIS and DIABETES MELLITUS, TYPE 2. It also binds AMYLOID BETA PEPTIDES; ALARMINS; S100A12 PROTEIN and S100 CALCIUM BINDING PROTEIN BETA SUBUNIT.; A single-pass transmembrane CELL SURFACE RECEPTOR that binds ADVANCED GLYCATION END PRODUCTS to mediate cellular responses to both acute and chronic vascular inflammation in conditions such as ATHEROSCLEROSIS and DIABETES MELLITUS, TYPE 2.;

MeSH synonym : AGE Receptor; RAGE (Receptor for Advanced Glycation End Products); Amphoterin Receptor; Receptor, Amphoterin; Receptor for Advanced Glycation End Products (RAGE); Receptor for Advanced Glycation Endproducts; AGER Protein; Receptor For Advanced Glycation End Product; Receptor for Advanced Glycation Endproduct; Advanced Glycation End Product Receptor; Advanced Glycation End Product Receptors;

CISMeF synonym : Protein, AGER; Receptor, AGE; Advanced Glycosylation End Product Specific Receptor; Advanced Glycosylation End Product Receptors; Advanced Glycosylation End-Product Receptor; Advanced Glycosylation End Product Receptor; Receptor, Advanced Glycosylation End-Product; Receptor, Advanced Glycosylation End Product; Receptor, Advanced Glycosylation End-Products; Receptor, Advanced Glycosylation End Products; Advanced Glycosylation End-Product Receptors; Advanced Glycosylation Endproduct Receptors; Advanced Glycosylation End Product-Specific Receptor; Advanced Glycosylation Endproduct Receptor;

Wikipedia automatic translation : Rage;

Wikipedia link : https://en.wikipedia.org/wiki/Rage;

Details


Main resources

You can consult :

A single-pass transmembrane CELL SURFACE RECEPTOR that binds ADVANCED GLYCOSYLATION END PRODUCTS to mediate cellular responses to both acute and chronic vascular inflammation in conditions such as ATHEROSCLEROSIS and DIABETES MELLITUS, TYPE 2 . It also binds AMYLOID BETA PEPTIDES and the alarmins S100A12 and S100 CALCIUM BINDING PROTEIN BETA SUBUNIT.
A single-pass transmembrane CELL SURFACE RECEPTOR that binds ADVANCED GLYCATION END PRODUCTS to mediate cellular responses to both acute and chronic vascular inflammation in conditions such as ATHEROSCLEROSIS and DIABETES MELLITUS, TYPE 2. It also binds AMYLOID BETA PEPTIDES and the ALARMINS - S100A12 and S100 CALCIUM BINDING PROTEIN BETA SUBUNIT.
A single-pass transmembrane CELL SURFACE RECEPTOR that binds ADVANCED GLYCATION END PRODUCTS to mediate cellular responses to both acute and chronic vascular inflammation in conditions such as ATHEROSCLEROSIS and DIABETES MELLITUS, TYPE 2. It also binds AMYLOID BETA PEPTIDES; ALARMINS; S100A12 PROTEIN and S100 CALCIUM BINDING PROTEIN BETA SUBUNIT.
A single-pass transmembrane CELL SURFACE RECEPTOR that binds ADVANCED GLYCATION END PRODUCTS to mediate cellular responses to both acute and chronic vascular inflammation in conditions such as ATHEROSCLEROSIS and DIABETES MELLITUS, TYPE 2.

https://www.canada.ca/fr/sante-publique/services/rapports-publications/releve-maladies-transmissibles-canada-rmtc/numero-mensuel/2023-49/numero-6-juin-2023/personnes-agees-non-reaction-prophylaxie-post-exposition-contre-rage.html
2023
Canada
journal article
prophylactic treatment, nos
Exhibition
Receptor for Advanced Glycation End Products
Post-Exposure prophylaxis
aged, 80 and over
aged
effects of exposure to external cause, nos
elderly person, nos
rabies
rabies, nos
Rabies

---
https://www.infovac.fr/vaccins/maladies-evitables/rage
2023
France
scientific and technical information
rabies, nos
Protein S100-A12
AGER wt Allele
Receptor for Advanced Glycation End Products
Rabies
Receptor Advanced Glycation Endproducts Measurement
rabies
MOK wt Allele
MAPK/MAK/MRK Overlapping Kinase
Advanced Glycosylation End Product-Specific Receptor
Rabeprazole Sodium

---
https://www.anses.fr/fr/content/la-rage
2022
France
popular works
Receptor for Advanced Glycation End Products
Rabies
rabies, nos
rabies

---
https://www.medg.fr/rage
2019
France
teaching material
scientific and technical information
Receptor for Advanced Glycation End Products
Rabies
rabies, nos
rabies

---
http://www.avisdexperts.ch/videos/view/7980
2018
false
false
false
Switzerland
French
radio broadcast
video recording
Receptor for Advanced Glycation End Products
rabies
rabies, nos
rabies

---
https://dumas.ccsd.cnrs.fr/dumas-01970417/document
2018
France
dissertations, academic
pilot projects
Receptor for Advanced Glycation End Products
rabies, nos
Evaluation Study
Pilots
prophylactic treatment, nos
injections, intramuscular
rabies
Rabies
review literature as topic
Immunogenicity, Vaccine
immunization schedule
Literature
Evaluation Study
Pilots
rabies

---
http://www.rfi.fr/emission/20170927-journee-mondiale-rage
2017
false
false
false
France
French
radio broadcast
rabies
Receptor for Advanced Glycation End Products
rabies, nos
rabies

---
http://publications.msss.gouv.qc.ca/msss/document-001653/
2016
false
false
false
France
French
technical report
mice
bat, nos
chiroptera
rabies, nos
rabies
Receptor for Advanced Glycation End Products
rabies
mice

---
Nous contacter.
24/05/2024


[Home] [Top]

© Rouen University Hospital. Any partial or total use of this material must mention the source.